Financials·Investment Banking & Brokerage·$29.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.61 | N/A | +11.09% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.61 | N/A | +11.09% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on earnings performance. They emphasized their commitment to maintaining strong financial health.
Management expressed satisfaction with the EPS performance despite the lack of revenue data.
They highlighted ongoing efforts to improve operational efficiency.
Raymond James Financial's earnings report shows a solid EPS performance, exceeding expectations by over 11%. The stock's slight increase of 0.34% reflects investor confidence in the company's ability to manage costs effectively. However, the absence of revenue data and guidance may leave some investors cautious about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
RESMED INC
Jan 22, 2018